Navellier & Associates’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-20,212
| Closed | -$1.11M | – | 277 |
|
|
2020
Q3 | $1.11M | Buy |
20,212
+60
| +0.3% | +$3.29K | 0.24% | 99 |
|
|
2020
Q2 | $1.07M | Buy |
+20,152
| New | +$1.07M | 0.25% | 94 |
|
|
2019
Q2 | – | Sell |
-40,507
| Closed | -$1.64M | – | 273 |
|
|
2019
Q1 | $1.64M | Sell |
40,507
-10
| -0% | -$404 | 0.25% | 104 |
|
|
2018
Q4 | $1.54M | Buy |
+40,517
| New | +$1.54M | 0.26% | 85 |
|
|
2015
Q4 | – | Sell |
-32
| Closed | -$1K | – | 233 |
|
|
2015
Q3 | $1K | Sell |
32
-7,792
| -100% | -$244K | ﹤0.01% | 301 |
|
|
2015
Q2 | $249K | Buy |
7,824
+564
| +8% | +$17.9K | 0.02% | 309 |
|
|
2015
Q1 | $248K | Sell |
7,260
-458
| -6% | -$15.6K | 0.02% | 303 |
|
|
2014
Q4 | $272K | Sell |
7,718
-56
| -0.7% | -$1.97K | 0.01% | 271 |
|
|
2014
Q3 | $278K | Buy |
+7,774
| New | +$278K | 0.01% | 269 |
|